{"id":"https://genegraph.clinicalgenome.org/r/d96f1560-a310-42a4-8df7-b3403fdfd550v1.0","type":"EvidenceStrengthAssertion","dc:description":"There is abundant evidence published associating the POLH gene with xeroderma pigmentosum variant type since the gene-disease relationship was first proposed by Masutani et al. (1999). Multiple case level studies have been performed with XPV patients that have variants in the POLH gene. 8 complementation groups genes (XPA, XPB, XPC, XPD, XPE, XPF, XPG, and XP variant (XPV)) in Nucleotide excision repair (NER) pathway were reported to cause Xeroderma Pigmentosum. Multiple Polh deficient mouse models have been established to show consistent phenotypes with XPV patients, including highly susceptible to ultraviolet-induced carcinogenesis and the formation of epithelial and mesenchymal tumors. All of these types of evidence are consistent with a definitive relationship between the POLH gene and xeroderma pigmentosum variant type.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/d96f1560-a310-42a4-8df7-b3403fdfd550","GCISnapshot":"https://genegraph.clinicalgenome.org/r/bdb29404-0c05-4519-b6ee-8591368ad1ff","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/bdb29404-0c05-4519-b6ee-8591368ad1ff_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2020-09-01T00:00:00Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/bdb29404-0c05-4519-b6ee-8591368ad1ff_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2018-11-02T21:58:46.146Z","role":"Approver"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bdb29404-0c05-4519-b6ee-8591368ad1ff_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bdb29404-0c05-4519-b6ee-8591368ad1ff_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/899ad07b-58f5-4d9a-919b-17d2dbdb2745","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7b963042-d7d5-4566-acde-319a2b1fcca8","type":"Finding","dc:description":"Fibroblasts derived from Polymerase h–deficient mice are sensitive to killing by exposure to UV light, and all Pol h–deficient mice develop skin tumors after UV irradiation, in contrast to the wild-type littermate controls that did not develop such tumors.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16397220","rdfs:label":"Increased Susceptibility to UV-Induced Skin Carcinogenesis","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/4906ec98-2535-4b1d-9028-8666890263d8","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/abb35970-3c9f-40bc-9d66-dba5ef260115","type":"Finding","dc:description":"Hypersensitivity of Polh\u0001 -/- fibroblasts to UV-C irradiation. Polh-deficient mice are prone to UV-induced skin cancers, like XP-V patients. Epithelial tumor formed in Polh\u0001-deficient mice after chronic UV irradiation. Polh Poli double-deficient mice show slightly earlier onset of skin tumor formation and also leads to the formation of mesenchymal tumors, such as sarcomas.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17015482","rdfs:label":"UV-B radiation induces epithelial tumors in mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/bdb29404-0c05-4519-b6ee-8591368ad1ff_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/68f3ce64-3eef-4bab-bb7a-6da1533c407c","type":"EvidenceLine","dc:description":"Eight genes","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/04c6f9b5-314a-448e-9de1-cc045bf00b9b","type":"Finding","dc:description":"8 complementation groups genes (XPA, XPB, XPC, XPD, XPE, XPF, XPG, and XP variant (XPV)) in Nucleotide excision repair (NER) pathway cause Xeroderma Pigmentosum.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24105368","rdfs:label":"8 complementation groups genes cause Xeroderma Pigmentosum","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/bdb29404-0c05-4519-b6ee-8591368ad1ff_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5fe8145b-e36f-43cb-a3a7-88d96d221172_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A G-to-T mutation at nucleotide 1153 which resulted in a glu306-to-ter mutation.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/31e0c00c-7e47-4a2c-ab39-34e25164352d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10385124","rdfs:label":"XP2SA","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0008069","obo:HP_0000992"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/5fe8145b-e36f-43cb-a3a7-88d96d221172_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10385124","allele":{"id":"https://genegraph.clinicalgenome.org/r/abf04043-3c7b-4bcc-ad7b-251a3093618d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006502.2(POLH):c.916G>T (p.Glu306Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/5887"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/f3aa0cee-f274-4bad-9ba6-e381b48740d3_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Deletion of 2 nucleotides at position 770-771.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/813367ad-fbd5-424e-8805-73b4afc9ff32","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10385124","rdfs:label":"XP7TA","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0008069","obo:HP_0000992"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/f3aa0cee-f274-4bad-9ba6-e381b48740d3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10385124","allele":{"id":"https://genegraph.clinicalgenome.org/r/81f6da5f-8562-408b-b656-f657674aab50","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"POLH, 2-BP DEL, NT770","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/5886"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/009228db-3f31-472e-922a-53113e85ab3c_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A C-to-T transition at nucleotide 1117, which created a premature termination codon in place of valine at codon 372.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/22201d5a-f451-4527-8523-5364e669e58a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10398605","rdfs:label":"XP115LO","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0000992","obo:HP_0008069"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/009228db-3f31-472e-922a-53113e85ab3c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10398605","allele":{"id":"https://genegraph.clinicalgenome.org/r/f4d486c6-c6cf-4fb6-b3c1-fb8dd4e8f33a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006502.2(POLH):c.1117C>T (p.Gln373Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/5890"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/03ae5b50-91a6-4add-838d-2f51174507cd_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A large genomic deletion that was not fully characterized. On the other allele, there was G-to-A mutation at nucleotide 1127 which resulted in a trp297-to-ter mutation.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0f02a0e1-2156-42f8-9ae9-e6b5bf7f8a39","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10385124","rdfs:label":"XP1RO","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0008069","obo:HP_0000992"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/03ae5b50-91a6-4add-838d-2f51174507cd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10385124","allele":{"id":"https://genegraph.clinicalgenome.org/r/01874d6b-b4f0-4fa0-96a3-e45b0a7d2852","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"POLH, DEL AND TRP297TER","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/5888"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/0523893e-923b-44d5-8114-fef18933eb22_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A C-to-T transition at nucleotide 376 of the POLH gene, resulting in the substitution of a premature termination codon for valine at codon 125.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/40afdda5-469c-4271-9d53-932d55c734cd","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10398605","rdfs:label":"XP1CH and XP2CH","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0008069","obo:HP_0000992"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/0523893e-923b-44d5-8114-fef18933eb22_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10398605","allele":{"id":"https://genegraph.clinicalgenome.org/r/8a504e3c-b408-44d0-a7f0-27558b437f8c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_006502.2(POLH):c.376C>T (p.Gln126Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/5889"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/c989d308-cef2-4fe9-a174-014957f9eec3_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Deletion of 13 nucleotides between positions 343 and 355.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0e23acbf-2a10-4b99-83d4-8e2740f870f3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10385124","rdfs:label":"XP30RO","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0000992","obo:HP_0008069"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/c989d308-cef2-4fe9-a174-014957f9eec3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10385124","allele":{"id":"https://genegraph.clinicalgenome.org/r/5fb7aae5-5b71-4eef-a51c-efcbf3e64a27","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"POLH, 13-BP DEL, NT343","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/5884"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/2a0ba187-7f4f-49bd-99e7-06c65f27a9e3_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A 104-bp deletion at nucleotides 661-764 of the POLH gene, resulting in a frameshift at lys220.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/20ee5d1f-edb6-40af-aeb9-83c18d97e2ba","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10398605","rdfs:label":"XP5MA","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0008069","obo:HP_0000992"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/2a0ba187-7f4f-49bd-99e7-06c65f27a9e3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10398605","allele":{"id":"https://genegraph.clinicalgenome.org/r/7019ea69-2b42-4ddb-990c-0267b4bb58cf","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"POLH, 104-BP DEL, NT661","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/5891"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/207d425d-0ae4-41a2-b18f-ec407cce9ca5_proband_score_evidence_line","type":"EvidenceLine","dc:description":"One was a -1 deletion of a G at nucleotide 207, resulting in a frameshift at lys69; the other was a 3-bp deletion at nucleotides 222-224 (603968.0011), resulting in an in-frame deletion of leu at codon 75.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/519fd004-7a4d-41ca-9b7b-ef09573ca7b4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10398605","rdfs:label":"XP6DU","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0000992","obo:HP_0008069"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/207d425d-0ae4-41a2-b18f-ec407cce9ca5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10398605","allele":[{"id":"https://genegraph.clinicalgenome.org/r/84fae7b7-4c87-4dcd-9af3-4f181c27c868","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"POLH, 3-BP DEL, NT222","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/5893"}},{"id":"https://genegraph.clinicalgenome.org/r/d51dc990-55d0-41cf-998f-c56dda364640","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"POLH, 1-BP DEL, 207G","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/5892"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/873beca6-0764-43a4-95bd-1c467b64b4e5_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Deletion of 4 nucleotides between positions 289 and 292.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0937a16d-66be-4a8a-bcbc-9f80b7b16f60","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10385124","rdfs:label":"XP4BE","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0000992","obo:HP_0008069"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/873beca6-0764-43a4-95bd-1c467b64b4e5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10385124","allele":{"id":"https://genegraph.clinicalgenome.org/r/80d0d1bb-bfc6-4da0-9d13-e704dcecbf61","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"POLH, 4-BP DEL, NT289","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/5885"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":166,"specifiedBy":"GeneValidityCriteria6","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/veaeJUwIa0k","type":"GeneValidityProposition","disease":"obo:MONDO_0010214","gene":"hgnc:9181","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_bdb29404-0c05-4519-b6ee-8591368ad1ff-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}